Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The company targets Gram-positive bacteria, including C. difficile, MRSA, VRE, DRSP, and B. anthracis.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.